Videos

ECRIN In A Nutshell

Language
English
Duration
4.00 minutes

In this European Institute for Innovation Through Health Data production, ECRIN's Director General, Jacques Demotes, explains why ECRIN is needed and what it does. In sum, ECRIN provides a wide range of support services to sponsors in the management of (investigator-initiated) multinational clinical trials. Watch the video to learn more!

Improve Your Managerial Skills with RItrain

Language
English
Duration
1.00 minutes

In this short video, ECRIN's Director General, Jacques Demotes, talks about why research infrastructure (RI) managers need specific training such as that provided through the RItrain project

Jacques Demotes - The Strategic Ecosystem: The Case of ECRIN

Language
English
Duration
37.00 minutes

In this video presentation, Director General Jacques Demotes presents ECRIN's organisation, services, tools, business model and strategy. 

Sail along with James Lind!

Language
English
Duration
5.00 minutes

This short animated video travels back in time to tell the story of the first clinical trial which took place in 1747 aboard a British naval ship (led by James Lind). It then goes on to explain how clinical trials work today. 

For the full video, go here

Partner Video: "What are Core Outcome Sets?" (A COMET Initiative video developed with patients & the public)

Language
English
Duration
3.00 minutes

This video explains what core outcome sets (COSs) are, why they are important, and how patients and the public are involved in developing COSs.

Video acknowledgement: “What are Core Outcome Sets” COMET Initiative video. 

Click here for more information on the COMET Initiative

Contact: Heather Bagley, COMET Patient and Public Involvement Coordinator, heather.bagley@liv.ac.uk

Marisa Papaluca on Personalised Medicine Regulatory Issues

Language
English
Duration
12.00 minutes

Interview with Marisa Papaluca, Senior Scientific Advisor, European Medicines Agency (EMA)

At ECRIN's International Clinical Trials Day (ICTD) 2016 meeting in Prague, Czech Republic, Marisa Papaluca responded to the following:

  • What are the main regulatory pathways and challenges for personalised medicine in Europe?
  • Can you provide a specific example of a regulatory issue and how it was resolved?

Ian Roberts on Methodological Considerations for Personalised Medicine

Language
English
Duration
6.00 minutes

Interview with Ian Roberts, Professor of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine (LSHTM)

At ECRIN's International Clinical Trials Day (ICTD) 2016 meeting in Prague, Czech Republic, Ian Roberts responded to the following:

  • What are the key methodological considerations of clinical trials on personalised medicine?
  • What are the main changes in methodological standards and expected impact?

Denis Horgan on Personalised Medicine Perspectives & Access

Language
English
Duration
4.00 minutes

Interview with Denis Horgan, Executive Director, European Alliance for Personalised Medicine

At ECRIN's International Clinical Trials Day (ICTD) 2016 meeting in Prague, Czech Republic, Denis Horgan responded to the following:

  • What are the main perspectives to consider when it comes to personalised medicine?
  • How can we make access to personalised medicine a reality for patients and ensure that the right treatment is provided to the right patient at the right time?

Dhavendra Kumar on Personalised & Evidence-Based Medicine

Language
English
Duration
15.00 minutes

Interview with Dhavendra Kumar, Consultant in Clinical Genetics, Institute of Cancer & Genetics, Cardiff University School of Medicine

At ECRIN's International Clinical Trials Day (ICTD) 2016 meeting in Prague, Czech Republic, Dhavendra Kumar responded to the following:

  • What is the definition of personalised medicine and evidence-based medicine, and what do they mean in relation to clinical trials?
  • What is the potential impact of evidence-based medicine on public health?